Benzodiazepine derivatives as GABA A gamma 1 PAM
US12365687B2 · kind B2 · utility
0Cited by
9References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 28, 2022 |
| Grant date | Jul 22, 2025 |
| Priority date | — |
| Expiry date | Sep 28, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/05
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention provides novel heterocyclic compounds having the general formula (I), and pharmaceutically acceptable salts thereof, wherein the variables are as described herein.Further provided are pharmaceutical compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds as medicaments, in particular methods of using the compounds for the treatment or prevention of acute neurological disorders, chronic neurological disorders and/or cognitive disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.